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Outline 
• Fundamentals 
• Advances 
– Growth factors 
– Platelet Rich Plasma 
– Engineered skin 
– Hyperbaric Oxygen Therapy 
•  Research 
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Skin Anatomy 
• Epidermis 
– Corneum 
– Lucidum 
– Granulosum 
– Spinosum 
– Basale 
• Dermis 
• Hypodermis 
Pilosebaceous Unit 
• Consists of: 
– hair follicle 
– sebaceous 
gland 
– eccrine gland 
– apocrine gland 
 
Wound Healing 
• Phases 
– Hemostasis-
Inflammation 
– Proliferation 
– Maturation- 
Remodeling 
Wound Healing 
Hemostasis: 
 
platelet 
activation 
 
Cellular 
influx 
Inflammatio
n 
 
Re-epithelialization 
 
Keratinocytes 
Angiogenesis 
 
 
Granulation 
tissue 
 
Fibroblasts 
Type III collagen now 
type I  
 
Fibroblast 
Apoptosis vs. 
Synthesis balance 
 
Excessive fibrosis 
lead to scar 
 
Wound Healing 
Macrophage: The QB 
Wound Healing: Growth Factors 
Growth Factor Biologic effect 
Platelet-derived growth factor (PDGF) Proliferation, chemotaxis, matrix synthesis 
Transforming growth factor- (TGF) Inflammation, granulation 
Vascular endothelial growth factor 
(VEGF) 
Angiogenesis 
Fibroblast growth factor (FGF) Granulation, re-epith 
Keratinocyte growth factor (KGF) Re-epithelialization 
Wound Healing: Growth Factors 
Dr. Harold Gillies 
Advances in Wound Healing:  
Exogenous Growth Factors 
• PDGF (Regranex) approved in 1998 by FDA for use in diabetic foot 
ulcers 
– EBM I, 48% vs 25%23 
• FGF 
– Venous ulcers, diabetic wounds24 
• Inconsistent results 
– Tympanic Membrane perforations 
• KGF 
– Mucositis 
• VEGF  
– Diabetic Ulcers 
 
23.  Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic 
ulcers. Diabetic Ulcer Study Group. J Vasc Surg 1995;21:71–8  
 
24.  Robson MC, Phillips LG, Lawrence WT, et al. The safety and effect of topically applied recombinant basic fibroblast growth factor 
on the healing of chronic pressure sores. Ann Surg 1992;216:401–6 
Recombinant Human basic Fibroblast 
Growth Factor  (b-FGF) 
Trafermin 
(Fifbrast)  
 



N = 56 
63 TMP  
10 gelfilm 
Outcomes measures 
• Closure 
• Hearing Level 
• Sx Sequela 
 
53 bFGF 
TMP s/p OM inflammation 
Old traumatic TMP 
TMP s/p tube 

Results 
Results 
Recombinant Human Keratinocyte 
Growth Factor (rhKGF) 


N = 212  
3x IV Placebo  
Intensive Therapy 
• Whole body irradiation 
• Chemotherapy 
• Bone Marrow Transplantation 
 
3x IV Palifermin 
3x additional 
doses after BMT 
Hodkin’s Disease 
Non-Hodgkin’s Lymphoma 
Leukemia 
Mutliple Myeloma 
Severe Mucositis 
63% vs. 98% 
3 days vs. 9 days 
29  vs. 46  
22.5 vs. 38.3 
Average healing time 
12 days vs. 25 days 
(VEGF vs control)  
Systemic absorption: 
18 days vs. 25 days ( 
PBS vs control)  
Growth Factors: Limitations 
• Cost 
– Regranex $586 per 15g tube 
• Delivery 
– Exception 
• Risk of Malignancy 
– 2008 retrospective study 
• Lack of data! 
Marie Curie: Portable X-ray 
Platelet Rich Plasma (PRP) 
Platelet Rich Plasma (PRP) 
Platelet-derived growth factor  
(PDGF) 
 
Epidermal Growth Factor  
(EGF) 
 
Transforming Growth Factor beta  
(TGF-β) 
 
Vascular Endothelial Growth 
Factor  
(VEGF) 
 
Fibroblast Growth Factor  
(bFGF) 
 
Epidermal Growth Factor  
(EGF) 
CaCl2 
Thrombin 
? 









N = 68  
Complications 
• 11 transient erythema 
• No resorption during f/u  
 
PRP-Scaffold 
Rhinoplasty 
No explantation 
of graft 
2005-2008 
Mean follow up 15 months 
PRP in Tympanic Membrane Perforations 
• Evidence in Rats 
– Accelerates 
• Case reports in humans with some success  
PRP: jury’s still out…. 
• Cochrane review 2012,  
– No difference in tx chronic wounds 
• “poor design of previous trials” 
Other applications… 
 
Bioengineered skin 
Tissue Material Tissue 
Layers 
Living Trade Name 
Cultured keratinocytes 
autograft 
Epidermal Yes 
Acellular free-dried 
cadaveric skin allograft 
Dermal No 
Bovine  
collagen/glycosaminoglyca
n/Silastic 
Dermal No 
Neonatal 
fibroblasts/polyglactin 
mesh allograft 
Dermal Yes 
Neonatal 
fribroblasts/keratinocytes 
collagen allograft 
Composite Yes 
Bioengineered skin: Apligraf 
• In vitro construct of human skin 
 
Neonatal foreskin 
Epidermal keratinocytes Dermal fibroblasts with a 
matrix of type I collagen 
Perform serial 
passage and culture 
Dermis: fibroblasts in collagen deposit,  
Epidermis: cultured keratinocytes on top of the dermis 
Bioengineered skin: Apligraf 
Hyperbaric Oxygen 
Hyperbaric Oxygen 
100mm Hg 
55mm Hg 
2000mm Hg 
500mm Hg 
1 atm 3 atm 
Hyperbaric Oxygen 
11 RCT, 
N = 669  
Significant 
Results: 
2001-2011 
2.) Following Surgical excision 
3.) Healing irradiated tooth 
sockets following dental 
extraction  
1.) Primary Tx of ORN 
• Animal studies 
– Decreased distal necrosis 
– Free flaps, allowed prolonged ischemia 
• Clinical studies  
– Cochrane review: 1 RCT STSG  
– “...high risk of bias” 
– “…more data needed” 
Dr. Harvey Cushing 
Research 
• Purpose: Characterize histologic and biochemical effects of age and 
exercise on axial based flaps. 
 
• Plan: Develop an animal model 
– Fasiculocutaneous flaps in Sprague Dawley rats 
– Perturb the model: age and exercise 
Design 
Pre Op 
Post Op 
Old vs. Young 
Histopathology 
Young Old 

VEGF  
Increasing Akt activation  
Apoptosis 
Initial Conclusions 
• Young vs. old 
– Increased VEGF 
– Increased Atk 
– Decreased apoptosis 
What this really means…. 
– Flaps do better 
• More vascular 
• Heal faster 
• Less necrosis 
Exercise? 
• 2 weeks of exercise prior to flap harvest 
• 4 groups 
– Old, Young +/- exercise 
Effect of Exercise: Young Rats 
Exercise Old Rats 
VEGF 
Conclusions 
• Cardiovascular exercise 
– Increase in VEGF in both exercising groups 
• Old exercising group higher response % increase in VEGF 
 
– Increase in Atk in both exercising groups 
  
Next Steps? 
• Other markers of 
wound healing 
– bFGF 
– EGF 
– PDGF 
• Effects of alcohol  
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